Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-16

Clinical Trial Update: Evaluation of Safety and Efficacy of Lumason in Pediatric Echocardiography [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Lumason in pediatric echocardiography was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMASON (sulfur hexafluoride lipid microspheres)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Heart Disease | Phase 3 | Status: TERMINATED | Results posted: 2020-06-16